A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan
Clinical trial NCT03311464 · COMPLETED
Trial details
- NCT number
- NCT03311464
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-27
- Primary completion
- 2019-08-20
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.